Hybio Pharmaceutical (300199) — Capital Reinvestment Ratio
Hybio Pharmaceutical (300199) has a Capital Reinvestment Ratio of 0.81x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥117.78 Million) in capital expenditures (CN¥95.60 Million). Check tangible net worth ratio of Hybio Pharmaceutical to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hybio Pharmaceutical Capital Reinvestment Ratio (2007–2024)
This chart tracks Hybio Pharmaceutical's Capital Reinvestment Ratio across 17 annual periods. For the full cash flow conversion analysis, see Hybio Pharmaceutical cash flow conversion.
Annual Capital Reinvestment Ratio for Hybio Pharmaceutical (2007–2024)
Year-by-year Capital Reinvestment Ratio for Hybio Pharmaceutical from 2007 to 2024. See Hybio Pharmaceutical free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.70x | CN¥164.71 Million | CN¥115.84 Million | ▼ -94.1% |
| 2022 | 12.01x | CN¥15.81 Million | CN¥189.85 Million | ▲ +846.5% |
| 2021 | 1.27x | CN¥156.83 Million | CN¥199.00 Million | ▼ -75.0% |
| 2020 | 5.08x | CN¥47.99 Million | CN¥243.66 Million | ▼ -6.8% |
| 2019 | 5.45x | CN¥104.64 Million | CN¥570.15 Million | ▼ -29.9% |
| 2018 | 7.78x | CN¥47.00 Million | CN¥365.58 Million | ▲ +651.8% |
| 2017 | 1.03x | CN¥213.74 Million | CN¥221.14 Million | ▲ +164.3% |
| 2016 | 0.39x | CN¥296.41 Million | CN¥116.05 Million | ▼ -84.9% |
| 2015 | 2.59x | CN¥138.84 Million | CN¥358.98 Million | ▲ +365.8% |
| 2014 | 0.56x | CN¥153.43 Million | CN¥85.16 Million | ▼ -71.9% |
| 2013 | 1.97x | CN¥153.48 Million | CN¥302.85 Million | ▼ -22.3% |
| 2012 | 2.54x | CN¥87.19 Million | CN¥221.38 Million | ▲ +135.1% |
| 2011 | 1.08x | CN¥72.48 Million | CN¥78.27 Million | ▲ +158.8% |
| 2010 | 0.42x | CN¥54.69 Million | CN¥22.83 Million | ▲ +21.0% |
| 2009 | 0.34x | CN¥26.11 Million | CN¥9.01 Million | ▼ -73.8% |
| 2008 | 1.32x | CN¥45.75 Million | CN¥60.28 Million | ▲ +1219.7% |
| 2007 | 0.10x | CN¥49.04 Million | CN¥4.90 Million | — |